Regeneron Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…

Biotechnology
US, Tarrytown [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Coles N Anthony
Director
$1,559 d cs
10% Holder
01/02/25
A
166 x $0 = $0
Goldstein Joseph L
Director
$6,548 d cs
10% Holder
01/02/25
A
166 x $0 = $0
Sing George L
Director
$27,828 d cs
10% Holder
01/02/25
A
166 x $0 = $0
Thompson Craig B.
Director
$620 d cs
10% Holder
01/02/25
A
166 x $0 = $0
Guarini Kathryn
Director
$448 d cs
10% Holder
01/02/25
A
166 x $0 = $0

Get PRO Today

With PRO you will unlock 453 more insider transactions for Regeneron Pharmaceuticals, Inc.